OMEGA-3-CARBOXYLIC ACIDS
| Brand name | EPANOVA |
|---|---|
| Active ingredient | OMEGA-3-CARBOXYLIC ACIDS |
| Strength | 1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDS |
| Dosage form | CAPSULE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | May 2014 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 10117844 | January 2033 | use U-2447 |
| 9050308 | January 2033 | use U-1511 |
| 9050309 | January 2033 | substance |
| 7960370 | December 2026 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.